PLN 2.37
(-1.25%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -79.01 Thousand PLN | -280.55% |
2022 | 43.76 Thousand PLN | -85.73% |
2021 | 306.59 Thousand PLN | -53.29% |
2020 | 656.32 Thousand PLN | 96.75% |
2019 | 333.58 Thousand PLN | 293.66% |
2018 | 84.73 Thousand PLN | 284.02% |
2017 | -46.04 Thousand PLN | 21.15% |
2016 | -58.4 Thousand PLN | -4295.55% |
2015 | 1392.00 PLN | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 8000.00 PLN | 100.76% |
2024 Q1 | -1.05 Million PLN | -246.77% |
2023 Q3 | -230 Thousand PLN | -66.67% |
2023 Q1 | -1000.00 PLN | 97.81% |
2023 Q2 | -138 Thousand PLN | -13700.0% |
2023 FY | -3.36 Million PLN | -7794.62% |
2023 Q4 | -303.94 Thousand PLN | -32.15% |
2022 Q2 | 1.65 Million PLN | 198.82% |
2022 FY | 43.76 Thousand PLN | -85.73% |
2022 Q4 | -45.75 Thousand PLN | -141.84% |
2022 Q3 | 109.36 Thousand PLN | -93.41% |
2022 Q1 | -1.67 Million PLN | -140.27% |
2021 Q1 | -1.07 Million PLN | -161.22% |
2021 Q2 | 1.02 Million PLN | 195.49% |
2021 FY | 306.59 Thousand PLN | -53.29% |
2021 Q3 | -3.81 Million PLN | -472.66% |
2021 Q4 | 4.16 Million PLN | 209.3% |
2020 Q2 | 113.27 Thousand PLN | 9068.13% |
2020 Q1 | 1235.53 PLN | -99.9% |
2020 FY | 656.32 Thousand PLN | 96.75% |
2020 Q4 | 1.75 Million PLN | 244.82% |
2020 Q3 | -1.2 Million PLN | -1167.18% |
2019 Q2 | -19.86 Thousand PLN | -109.83% |
2019 Q1 | 202.06 Thousand PLN | -91.55% |
2019 FY | 333.58 Thousand PLN | 293.66% |
2019 Q3 | -1.04 Million PLN | -5164.83% |
2019 Q4 | 1.19 Million PLN | 214.47% |
2018 Q2 | -127.06 Thousand PLN | -4435.72% |
2018 Q3 | -2.17 Million PLN | -1613.51% |
2018 FY | 84.73 Thousand PLN | 284.02% |
2018 Q4 | 2.39 Million PLN | 209.86% |
2018 Q1 | -2801.32 PLN | -100.22% |
2017 Q2 | 16.93 Thousand PLN | -35.02% |
2017 FY | -46.04 Thousand PLN | 21.15% |
2017 Q3 | -1.31 Million PLN | -7885.29% |
2017 Q1 | 26.06 Thousand PLN | 0.0% |
2017 Q4 | 1.27 Million PLN | 196.9% |
2016 FY | -58.4 Thousand PLN | -4295.55% |
2015 FY | 1392.00 PLN | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Bioceltix S.A. | -1.03 Million PLN | 92.388% |
BIOTON S.A. | 72.85 Million PLN | 100.108% |
Captor Therapeutics Spolka Akcyjna | 6.9 Million PLN | 101.145% |
Mabion S.A. | 114.58 Million PLN | 100.069% |
Molecure S.A. | -4.1 Million PLN | 98.074% |
Pharmena S.A. | 5.84 Million PLN | 101.352% |
Poltreg S.A. | -1.38 Million PLN | 94.303% |
Pure Biologics Spólka Akcyjna | -2.57 Million PLN | 96.93% |
Ryvu Therapeutics S.A. | 29.3 Million PLN | 100.27% |
Synthaverse S.A. | 35.16 Million PLN | 100.225% |
Urteste S.A. | -479 Thousand PLN | 83.504% |